Wiffen L - Search Results

1

Diagnosis and Severity Assessment of COPD Using a Novel Fast-Response Capnometer and Interpretable Machine Learning.

Talker L, Dogan C, Neville D, Lim RH, Broomfield H, Lambert G, Selim A, Brown T, Wiffen L, Carter J, Ashdown HF, Hayward G, Vijaykumar E, Weiss ST, Chauhan A, Patel AX. Talker L, et al. Among authors: wiffen l. COPD. 2024 Dec;21(1):2321379. doi: 10.1080/15412555.2024.2321379. Epub 2024 Apr 24. COPD. 2024. PMID: 38655897

2

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22. Lancet Child Adolesc Health. 2024. PMID: 38272046 Free article. Clinical Trial.

3

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

4

Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learning.

Wiffen L, D'Cruz LG, Brown T, Higenbottam TW, Bernstein JA, Campbell C, Moellman J, Ghosh D, Richardson C, Weston-Davies W, Chauhan AJ. Wiffen L, et al. Front Immunol. 2023 Sep 5;14:1192765. doi: 10.3389/fimmu.2023.1192765. eCollection 2023. Front Immunol. 2023. PMID: 37731491 Free PMC article.

5

Capability, Opportunity, and Motivation Model for Behavior Change in People With Asthma: Protocol for a Cross-Sectional Study.

Munns A, Wiffen L, Brown T, Fasulo A, Chauhan M, D'Cruz L, Kaklamanou D, Chauhan AJ. Munns A, et al. Among authors: wiffen l. JMIR Res Protoc. 2023 Jul 6;12:e44710. doi: 10.2196/44710. JMIR Res Protoc. 2023. PMID: 37410518 Free PMC article.

6

Machine diagnosis of chronic obstructive pulmonary disease using a novel fast-response capnometer.

Talker L, Neville D, Wiffen L, Selim AB, Haines M, Carter JC, Broomfield H, Lim RH, Lambert G; BRS Study Team; Weiss ST, Hayward G, Brown T, Chauhan A, Patel AX. Talker L, et al. Among authors: wiffen l. Respir Res. 2023 Jun 2;24(1):150. doi: 10.1186/s12931-023-02460-z. Respir Res. 2023. PMID: 37268935 Free PMC article.

7

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.

8

Measurement of Vital Signs by Lifelight Software in Comparison to Standard of Care Multisite Development (VISION-MD): Protocol for an Observational Study.

Wiffen L, Brown T, Brogaard Maczka A, Kapoor M, Pearce L, Chauhan M, Chauhan AJ, Saxena M; Lifelight Trials Group. Wiffen L, et al. JMIR Res Protoc. 2023 Jan 11;12:e41533. doi: 10.2196/41533. JMIR Res Protoc. 2023. PMID: 36630158 Free PMC article.

9

Measurement of Vital Signs Using Lifelight Remote Photoplethysmography: Results of the VISION-D and VISION-V Observational Studies.

Heiden E, Jones T, Brogaard Maczka A, Kapoor M, Chauhan M, Wiffen L, Barham H, Holland J, Saxena M, Wegerif S, Brown T, Lomax M, Massey H, Rostami S, Pearce L, Chauhan A. Heiden E, et al. Among authors: wiffen l. JMIR Form Res. 2022 Nov 14;6(11):e36340. doi: 10.2196/36340. JMIR Form Res. 2022. PMID: 36374541 Free PMC article.

10

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial.

Keir HR, Long MB, Abo-Leyah H, Giam YH, Vadiveloo T, Pembridge T, Hull RC, Delgado L, Band M, McLaren-Neil F, Adamson S, Lahnsteiner E, Gilmour A, Hughes C, New BJ, Connell D, Dowey R, Turton H, Richardson H, Cassidy D, Cooper J, Suntharalingam J, Diwakar L, Russell P, Underwood J, Hicks A, Dosanjh DP, Sage B, Dhasmana D, Spears M, Thompson AR, Brightling C, Smith A, Patel M, George J, Condliffe AM, Shoemark A, MacLennan G, Chalmers JD; STOP-COVID19 Investigators. Keir HR, et al. Lancet Respir Med. 2022 Dec;10(12):1119-1128. doi: 10.1016/S2213-2600(22)00261-2. Epub 2022 Sep 5. Lancet Respir Med. 2022. PMID: 36075243 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page